Phil Doren

CEO & VP at Abond CRO

Phil Doren began their career in 1991 as Director of Clinical Monitoring for Kendle International Inc. / ACERExcel. Phil held this position for 12 years before moving on to TKL Research in 1999, where they served as Vice President of Clinical Operations for three years. In 2002, they became Vice President of Diagnostic Professional Services for eResearch Technology, and in 2003 they joined Covance Inc. as Vice President and Global Head of Clinical Data, Analysis, and Reporting Organization. Phil remained with Covance until 2008, when they accepted a position as Vice President, Head of Biostatistics - North America with Quintiles. Phil held this position until 2012 when they left to join SynteractHCR, Inc. as Global Vice President, Biometrics. In 2015, they became General Manager and Vice President of Clinical Operations for Everest Clinical Research, and in 2016 they were appointed CEO & VP at Abond CRO. Phil Doren is currently serving as Pharma/Biotech Industry Executive Consultant for Pharma Integration a to z.

Phil Doren's educational career includes a B.S. from the University of Minnesota, a Ph.D. from Texas A&M University, and an M.S. from Texas A&M University.

Some direct reports include Danita Harris - Executive Director, Clinical Data Management, Brian Armstrong - Senior Director of Clinical Data Standards & Statistical Programming, and Stephine Keeton - Senior Director of Statistics.

Links

Previous companies

IQVIA logo

Timeline

  • CEO & VP

    Current role